Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist

Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist

US Patent 11253514 · Granted Feb 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Amorphous pharmaceutical compositions of abiraterone acetate2025
Amorphous pharmaceutical compositions of abiraterone acetate2025
Substituted piperidines and piperazines and methods for the treatment of CNS dis2025
Substituted piperidines and piperazines and methods for the treatment of CNS dis2025
Substituted piperidines and piperazines and methods for the treatment of CNS dis2025
Substituted piperidines and piperazines and methods for the treatment of CNS dis2025
Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disord2025
Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disord2025
Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disord2025
Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disord2025
Uses of a 5-HT4 receptor agonist2025
Uses of a 5-HT4 receptor agonist2025